Donepezil and Memantine in Moderate to Severe Alzheimer's Disease.

Trial Profile

Donepezil and Memantine in Moderate to Severe Alzheimer's Disease.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Donepezil (Primary) ; Memantine (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Acronyms DOMINO-AD
  • Most Recent Events

    • 22 Aug 2013 Accrual to date is 37% according to United Kingdom Clinical Research Network record.
    • 08 Mar 2012 Results published in the New England Journal of Medicine.
    • 12 Jul 2011 New source identified and integrated (European Clinical Trials Database record).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top